|
1
|
ARISE; ANZICS APD Management Committee:
The outcome of patients with sepsis and septic shock presenting to
emergency departments in Australia and New Zealand. Crit Care
Resusc. 9:8–18. 2007.PubMed/NCBI
|
|
2
|
Kumar G, Kumar N, Taneja A, Kaleekal T,
Tarima S, McGinley E, Jimenez E, Mohan A, Khan RA, Whittle J, et
al: Nationwide trends of severe sepsis in the 21st century
(2000–2007). Chest. 140:1223–1231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hartman ME, Linde-Zwirble WT, Angus DC and
Watson RS: Trends in the epidemiology of pediatric severe
sepsis*. Pediatr Crit Care Med. 14:686–693. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lagu T, Rothberg MB, Shieh MS, Pekow PS,
Steingrub JS and Lindenauer PK: Hospitalizations, costs, and
outcomes of severe sepsis in the United States 2003 to 2007. Crit
Care Med. 40:754–761. 2012. View Article : Google Scholar
|
|
5
|
Sakr Y, Elia C, Mascia L, Barberis B,
Cardellino S, Livigni S, Fiore G, Filippini C and Ranieri VM:
Epidemiology and outcome of sepsis syndromes in Italian ICUs: A
muticentre, observational cohort study in the region of Piedmont.
Minerva Anestesiol. 79:993–1002. 2013.PubMed/NCBI
|
|
6
|
Caironi P, Tognoni G, Masson S, Fumagalli
R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli
G, et al: Albumin replacement in patients with severe sepsis or
septic shock. N Engl J Med. 370:1412–1421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
ProCESS Investigators; Yealy DM, Kellum
JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang
HE, Hou PC, et al: A randomized trial of protocol-based care for
early septic shock. N Engl J Med. 370:1683–1693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitka M: Drug for severe sepsis is
withdrawn from market, fails to reduce mortality. JAMA.
306:2439–2440. 2011.PubMed/NCBI
|
|
9
|
Schulte W, Bernhagen J and Bucala R:
Cytokines in sepsis: Potent immunoregulators and potential
therapeutic targets-an updated view. Mediators Inflamm.
2013:1659742013. View Article : Google Scholar
|
|
10
|
Shahkar L, Keshtkar A, Mirfazeli A, Ahani
A and Roshandel G: The role of IL-6 for predicting neonatal sepsis:
A systematic review and meta-analysis. Iran J Pediatr. 21:411–417.
2011.
|
|
11
|
Schrag B, Roux-Lombard P, Schneiter D,
Vaucher P, Mangin P and Palmiere C: Evaluation of C-reactive
protein, procalcitonin, tumor necrosis factor alpha, interleukin-6,
and interleukin-8 as diagnostic parameters in sepsis-related
fatalities. Int J Legal Med. 126:505–512. 2012. View Article : Google Scholar
|
|
12
|
Song R, Kim J, Yu D, Park C and Park J:
Kinetics of IL-6 and TNF-α changes in a canine model of sepsis
induced by endotoxin. Vet Immunol Immunopathol. 146:143–149. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bozza FA, Salluh JI, Japiassu AM, Soares
M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC and Bozza PT:
Cytokine profiles as markers of disease severity in sepsis: A
multiplex analysis. Crit Care. 11:R492007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chuang TY, Chang HT, Chung KP, Cheng HS,
Liu CY, Liu YC, Huang HH, Chou TC, Chang BL, Lee MR, et al: High
levels of serum macrophage migration inhibitory factor and
interleukin 10 are associated with a rapidly fatal outcome in
patients with severe sepsis. Int J Infect Dis. 20:13–17. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mei SH, Haitsma JJ, Dos Santos CC, Deng Y,
Lai PF, Slutsky AS, Liles WC and Stewart DJ: Mesenchymal stem cells
reduce inflammation while enhancing bacterial clearance and
improving survival in sepsis. Am J Respir Crit Care Med.
182:1047–1057. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nemeth K, Leelahavanichkul A, Yuen PS,
Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller
BH, Brown JM, et al: Bone marrow stromal cells attenuate sepsis via
prostaglandin E(2)-dependent reprogramming of host macrophages to
increase their interleukin-10 production. Nat Med. 15:42–49. 2009.
View Article : Google Scholar
|
|
17
|
Gupta N, Su X, Popov B, Lee JW, Serikov V
and Matthay MA: Intrapulmonary delivery of bone marrow-derived
mesenchymal stem cells improves survival and attenuates
endotoxin-induced acute lung injury in mice. J Immunol.
179:1855–1863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Qu J, Cao L, Sai Y, Chen C, He L and
Yu L: Mesenchymal stem cell-based angiopoietin-1 gene therapy for
acute lung injury induced by lipopolysaccharide in mice. J Pathol.
214:472–481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krasnodembskaya A, Samarani G, Song Y,
Zhuo H, Su X, Lee JW, Gupta N, Petrini M and Matthay MA: Human
mesenchymal stem cells reduce mortality and bacteremia in
gram-negative sepsis in mice in part by enhancing the phagocytic
activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol.
302:L1003–L1013. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sepúlveda JC, Tomé M, Fernández ME,
Delgado M, Campisi J, Bernad A and González MA: Cell senescence
abrogates the therapeutic potential of human mesenchymal stem cells
in the lethal endotoxemia model. Stem Cells. 32:1865–1877. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
in't Anker PS, Noort WA, Scherjon SA,
Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL,
Beekhuizen W, Willemze R, Kanhai HH and Fibbe WE: Mesenchymal stem
cells in human second-trimester bone marrow, liver, lung, and
spleen exhibit a similar immunophenotype but a heterogeneous
multilineage differentiation potential. Haematologica. 88:845–852.
2003.
|
|
22
|
Dmitrieva RI, Minullina IR, Bilibina AA,
Tarasova OV, Anisimov SV and Zaritskey AY: Bone marrow- and
subcutaneous adipose tissue-derived mesenchymal stem cells:
differences and similarities. Cell Cycle. 11:377–383. 2012.
View Article : Google Scholar
|
|
23
|
Zappia E, Casazza S, Pedemonte E,
Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti
F, Frassoni F, et al: Mesenchymal stem cells ameliorate
experimental autoimmune encephalomyelitis inducing T-cell anergy.
Blood. 106:1755–1761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: Implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gonzalez-Rey E, Anderson P, Gonzalez MA,
Rico L, Büscher D and Delgado M: Human adult stem cells derived
from adipose tissue protect against experimental colitis and
sepsis. Gut. 58:929–939. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Puissant B, Barreau C, Bourin P, Clavel C,
Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, et
al: Immunomodulatory effect of human adipose tissue-derived adult
stem cells: Comparison with bone marrow mesenchymal stem cells. Br
J Haematol. 129:118–129. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shin S, Kim Y, Jeong S, Hong S, Kim I, Lee
W and Choi S: The therapeutic effect of human adult stem cells
derived from adipose tissue in endotoxemic rat model. Int J Med
Sci. 10:8–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu X, Chen Y, Xie FN, Dong P, Liu WB, Cao
Y, Zhang WJ and Xiao R: Comparison of immunological characteristics
of mesenchymal stem cells derived from human embryonic stem cells
and bone marrow. Tissue Eng Part A. 21:616–626. 2015. View Article : Google Scholar :
|
|
29
|
Elman JS, Li M, Wang F, Gimble JM and
Parekkadan B: A comparison of adipose and bone marrow-derived
mesenchymal stromal cell secreted factors in the treatment of
systemic inflammation. J Inflamm (Lond). 11:12014. View Article : Google Scholar
|
|
30
|
Zhao J, Wang G, Zhang H and Fu X:
Isolation, cultivation, purification and identification of mice
bone marrow mesenchyaml stem cells in vitro. Chin J Lab Diagn.
16:11–13. 2012.In Chinese.
|
|
31
|
Soleimani M and Nadri S: A protocol for
isolation and culture of mesenchymal stem cells from mouse bone
marrow. Nat Protoc. 4:102–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu S, Lei J, Li Y, Xiang P and Zhou D:
Isolation, identification and biological characteristics of mouse
adipose-derived stromal cells. J Sun Yat-Sen University (Medical
Sciences). 33:299–304. 2012.In Chinese.
|
|
33
|
Kim SR, Ha YM, Kim YM, Park EJ, Kim JW,
Park SW, Kim HJ, Chung HT and Chang KC: Ascorbic acid reduces HMGB1
secretion in lipopolysaccharide-activated RAW 264.7 cells and
improves survival rate in septic mice by activation of Nrf2/HO-1
signals. Biochem Pharmacol. 95:279–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kushimoto S, Gando S, Saitoh D, Mayumi T,
Ogura H, Fujishima S, Araki T, Ikeda H, Kotani J, Miki Y, et al:
The impact of body temperature abnormalities on the disease
severity and outcome in patients with severe sepsis: An analysis
from a multicenter, prospective survey of severe sepsis. Crit Care.
17:R2712013. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tiruvoipati R, Ong K, Gangopadhyay H,
Arora S, Carney I and Botha J: Hypothermia predicts mortality in
critically ill elderly patients with sepsis. BMC Geriatr.
10:702010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Granger JI, Ratti PL, Datta SC, Raymond RM
and Opp MR: Sepsis-induced morbidity in mice: Effects on body
temperature, body weight, cage activity, social behavior and
cytokines in brain. Psychoneuroendocrinology. 38:1047–1057. 2013.
View Article : Google Scholar :
|
|
37
|
Shi DW, Zhang J, Jiang HN, Tong CY, Gu GR,
Ji Y, Summah H and Qu JM: LPS pretreatment ameliorates multiple
organ injuries and improves survival in a murine model of
polymicrobial sepsis. Inflamm Res. 60:841–849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Novotny AR, Reim D, Assfalg V, Altmayr F,
Friess HM, Emmanuel K and Holzmann B: Mixed antagonist response and
sepsis severity-dependent dysbalance of pro- and anti-inflammatory
responses at the onset of postoperative sepsis. Immunobiology.
217:616–621. 2012. View Article : Google Scholar
|
|
39
|
Osuchowski MF, Welch K, Siddiqui J and
Remick DG: Circulating cytokine/inhibitor profiles reshape the
understanding of the SIRS/CARS continuum in sepsis and predict
mortality. J Immunol. 177:1967–1974. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mei SH, McCarter SD, Deng Y, Parker CH,
Liles WC and Stewart DJ: Prevention of LPS-induced acute lung
injury in mice by mesenchymal stem cells overexpressing
angiopoietin 1. PLoS Med. 4:e2692007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hack CE, Aarden LA and Thijs LG: Role of
cytokines in sepsis. Adv Immunol. 66:101–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hechtman DH, Cybulsky MI, Fuchs HJ, Baker
JB and Gimbrone MA Jr: Intravascular IL-8. Inhibitor of
polymorpho-nuclear leukocyte accumulation at sites of acute
inflammation. J Immunol. 147:883–892. 1991.PubMed/NCBI
|
|
43
|
Collins PD, Jose PJ and Williams TJ: The
sequential generation of neutrophil chemoattractant proteins in
acute inflammation in the rabbit in vivo. Relationship between C5a
and proteins with the characteristics of IL-8/neutrophil-activating
protein 1. J Immunol. 146:677–684. 1991.PubMed/NCBI
|
|
44
|
Chen HC, Lin HC, Liu CY, Wang CH, Hwang T,
Huang TT, Lin CH and Kuo HP: Neutrophil elastase induces IL-8
synthesis by lung epithelial cells via the mitogen-activated
protein kinase pathway. J Biomed Sci. 11:49–58. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Harada A, Sekido N, Akahoshi T, Wada T,
Mukaida N and Matsushima K: Essential involvement of interleukin-8
(IL-8) in acute inflammation. J Leukoc Biol. 56:559–564.
1994.PubMed/NCBI
|
|
46
|
Ramaiah SK and Jaeschke H: Role of
neutrophils in the pathogenesis of acute inflammatory liver injury.
Toxicol Pathol. 35:757–766. 2007. View Article : Google Scholar : PubMed/NCBI
|
